These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25281742)

  • 21. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor.
    Persson E; Nielsen LS; Olsen OH
    Biochemistry; 2001 Mar; 40(11):3251-6. PubMed ID: 11258943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain.
    Sørensen BB; Freskgård PO; Nielsen LS; Rao LV; Ezban M; Petersen LC
    J Biol Chem; 1999 Jul; 274(30):21349-54. PubMed ID: 10409695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.
    Guo D; Zhou H; Wu Y; Zhou F; Xu G; Wen H; Zhang X
    Tumour Biol; 2011 Oct; 32(5):921-30. PubMed ID: 21625939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The origins of enhanced activity in factor VIIa analogs and the interplay between key allosteric sites revealed by hydrogen exchange mass spectrometry.
    Rand KD; Andersen MD; Olsen OH; Jørgensen TJ; Ostergaard H; Jensen ON; Stennicke HR; Persson E
    J Biol Chem; 2008 May; 283(19):13378-87. PubMed ID: 18343822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines.
    Fox BP; Kandpal RP
    Cancer Genomics Proteomics; 2011; 8(4):185-93. PubMed ID: 21737611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential gene expression in activated monocyte-derived macrophages following binding of factor VIIa to tissue factor.
    Muth H; Kreis I; Zimmermann R; Tillmanns H; Hölschermann H
    Thromb Haemost; 2005 Nov; 94(5):1028-34. PubMed ID: 16363246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disulfide isomerization switches tissue factor from coagulation to cell signaling.
    Ahamed J; Versteeg HH; Kerver M; Chen VM; Mueller BM; Hogg PJ; Ruf W
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):13932-7. PubMed ID: 16959886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.
    Prasad R; Sen P
    Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey.
    Beeler DL; Aird WC; Grant MA
    J Thromb Haemost; 2018 Apr; 16(4):734-748. PubMed ID: 29418058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
    Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
    J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
    Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
    Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural modulation of factor VIIa by full-length tissue factor (TF
    Prasad R; Sen P
    J Biomol Struct Dyn; 2018 Feb; 36(3):621-633. PubMed ID: 28150568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
    Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
    Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
    Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue factor enhances protease-activated receptor-2-mediated factor VIIa cell proliferative properties.
    Fan L; Yotov WV; Zhu T; Esmailzadeh L; Joyal JS; Sennlaub F; Heveker N; Chemtob S; Rivard GE
    J Thromb Haemost; 2005 May; 3(5):1056-63. PubMed ID: 15869604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
    Ott I; Weigand B; Michl R; Seitz I; Sabbari-Erfani N; Neumann FJ; Schömig A
    Circulation; 2005 Jan; 111(3):349-55. PubMed ID: 15642762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex.
    Marutsuka K; Hatakeyama K; Sato Y; Yamashita A; Sumiyoshi A; Asada Y
    Thromb Res; 2002 Sep; 107(5):271-6. PubMed ID: 12479889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue factor activates allosteric networks in factor VIIa through structural and dynamic changes.
    Madsen JJ; Persson E; Olsen OH
    J Thromb Haemost; 2015 Feb; 13(2):262-7. PubMed ID: 25403348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy.
    Lazarus RA; Olivero AG; Eigenbrot C; Kirchhofer D
    Curr Med Chem; 2004 Sep; 11(17):2275-90. PubMed ID: 15379712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.